Freeline Therapeutics Holdings PLC (NASDAQ: FRLN) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 41.78% on the day to $5.26.
Freeline Therapeutics Holdings PLC, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in Phase 1/2 clinical trials in adult males for the treatment of hemophilia B. The company’s products also include FLT190.
So far today, approximately 12.17M shares of Freeline Therapeutics Holdings PLC have been exchanged, as compared to an average 30-day volume of 58,506 shares.
Freeline Therapeutics Holdings PLC share prices have moved between a 52-week high of $14.85 and a 52-week low of $2.11. The stock has moved 3.2% over the past week.
To learn more about Freeline Therapeutics Holdings PLC, visit the company’s website at https://www.freeline.life.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.
For more information, please visit https://www.InvestorBrandNetwork.com